Cargando…

Strategies for Optimizing Treatment Outcomes

Detalles Bibliográficos
Autor principal:	Jones Freeman, Elyce L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2003
Materias:	Cea
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437159/ https://www.ncbi.nlm.nih.gov/pubmed/14613356 http://dx.doi.org/10.18553/jmcp.2003.9.s1.20

Ejemplares similares

Introduction: Optimizing Outcomes Through Pharmaceutical Advances in the Treatment of Chronic Myeloid Leukemia
por: Frame, David
Publicado: (2007)

Treatment Strategies for Reducing the Burden of Menopause-Associated Vasomotor Symptoms
por: Umland, Elena M.
Publicado: (2008)

Identifying Indicators of Outcomes and Implementing Treatment Pathways
por: Huff, Carol Ann, et al.
Publicado: (2012)

Assessment of Disease Activity and Treatment Outcomes in Rheumatoid Arthritis
por: Farheen, Kiran, et al.
Publicado: (2011)

Emerging Therapeutic Strategies for Asthma Management
por: Sullivan, Sean D., et al.
Publicado: (2003)

New Strategies in Controlling Drug Resistance
por: Frame, David
Publicado: (2007)

Pharmacy Management Strategies for Improving Drug Adherence
por: Fleming, William K.
Publicado: (2008)

Practice Strategies to Improve Compliance and Patient Self-Management
por: Ruetsch, Charles
Publicado: (2010)

Collaborative Strategies for Improving Clinical Resource Utilization: How Pharmacists Can Make a Difference
por: Rodvold, Keith A.
Publicado: (2009)

Maximizing the Outcomes in Cancer Patients Receiving
por: Mucenski, John W., et al.
Publicado: (2003)

The Role of Outcomes Research in Defining and Measuring Value in Benefit Decision
por: Nichol, Michael B.
Publicado: (2006)

Considerations on the Use of Patient-Reported Outcomes in Comparative Effectiveness Research
por: Alemayehu, Demissie, et al.
Publicado: (2011)

Successful HIV Treatment
por: Cohen, Calvin J.
Publicado: (2006)

New Treatment Options in COPD
por: Hillman, Daniel E.
Publicado: (2005)

Opioid Dependence Treatment and Guidelines
por: Nicholls, Lance, et al.
Publicado: (2010)

Introduction: Targeted Evidenced-Based Colorectal Cancer Therapies: Shifting the Patient Outcome
por: Minkoff, Neil B.
Publicado: (2007)

Overview of Pharmacologic Therapy for the Treatment of Dyslipidemia
por: Lipsy, Robert J.
Publicado: (2003)

Influencing Patient Adherence to Treatment Guidelines
por: Butterworth, Susan W.
Publicado: (2008)

Improving Depression Treatment by Integrated Care
por: Rost, Kathryn M.
Publicado: (2005)

Current and Emerging Treatments for Multiple Myeloma
por: Schwartz, Rowena N., et al.
Publicado: (2008)

Challenges Facing Employers in the Treatment of Depression
por: Avery, Steven G.
Publicado: (2005)

Quest for Timely Detection and Treatment of Women With Depression
por: Alexander, Jeanne Leventhal
Publicado: (2007)

Emerging Trends for Prevention and Treatment of Diabetic Nephropathy
por: Hunsicker, Lawrence G.
Publicado: (2004)

Treatment-Resistant Depression: Managed Care Considerations
por: Tierney, John G.
Publicado: (2007)

Guidelines and Performance Measures for the Prevention and Treatment of Venous Thromboembolism
por: Fanikos, John
Publicado: (2008)

Improving Cost-Effectiveness of and Outcomes From Drug Therapy in Patients With Atrial Fibrillation in Managed Care: Role of the Pharmacist
por: Johnson, Samuel G.
Publicado: (2009)

Statistical Issues with the Analysis of Nonrandomized Studies in Comparative Effectiveness Research
por: Alemayehu, Demissie, et al.
Publicado: (2011)

A Budget-Impact and Cost-Effectiveness Model for Second-Line Treatment of Major Depression
por: Malone, Daniel C.
Publicado: (2007)

Disease Progression and the Application of Evidence-Based Treatment Guidelines Diagnose It Early: A Case for Screening and Appropriate Management
por: Manley, Harold J.
Publicado: (2007)

Implementing the New Guidelines for Hypertension
por: Carter, Barry L.
Publicado: (2004)

Merging P4P and Disease Management: How Do You Know Which One Is Working?
por: Smith, Allen L.
Publicado: (2007)

Current Perspectives on Hypertension and Metabolic Syndrome
por: Bakris, George L.
Publicado: (2007)

The Impact of Residual Cardiovascular Risk in Combination Lipid-Modifying Therapy in the Managed Care Setting
por: Talbert, Robert L.
Publicado: (2008)

Pharmacological Augmentation of Endothelium-Derived Nitric Oxide Synthesis
por: Bakris, George L.
Publicado: (2007)

Direct Renin Inhibition: Focus on Aliskiren
por: Pool, James L.
Publicado: (2007)

Case Study: The Link Between Hypertension and Diabetes
por: Bakris, George L., et al.
Publicado: (2007)

Introduction: Medicare Section 1013 and AHRQ's Effective Health Care Program
por: Chao, Schumarry H., et al.
Publicado: (2007)

Perspectives for Managed Care Organizations on the Burden of Multiple Sclerosis and the Cost-Benefits of Disease-Modifying Therapies
por: Owens, Gary M., et al.
Publicado: (2013)

Continuing Education
por: Carter, Barry L., et al.
Publicado: (2004)

Underidentification and Undertreatment Issues
por: Bottorff, Michael B.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_tub266k6gv3845iojrib0u321v